Ascend Wellness Holdings, Inc. Quarterly Cost of Revenue in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Ascend Wellness Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q3 2024.
  • Ascend Wellness Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $97.9M, a 0.21% increase year-over-year.
  • Ascend Wellness Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $381M, a 11.5% increase year-over-year.
  • Ascend Wellness Holdings, Inc. annual Cost of Revenue for 2023 was $363M, a 33.9% increase from 2022.
  • Ascend Wellness Holdings, Inc. annual Cost of Revenue for 2022 was $271M, a 38.2% increase from 2021.
  • Ascend Wellness Holdings, Inc. annual Cost of Revenue for 2021 was $196M, a 137% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $381M $97.9M +$206K +0.21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $381M $100M +$5.29M +5.59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $375M $90.4M +$11.9M +15.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $363M $92.6M +$22M +31.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $341M $97.7M +$23.1M +31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $318M $94.7M +$30.1M +46.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $288M $78.5M +$16.8M +27.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $271M $70.6M +$12.9M +22.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $258M $74.6M +$21.2M +39.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $237M $64.5M +$15.7M +32.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $222M $61.6M +$25.2M +69% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $196M $57.7M +$26.3M +83.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $170M $53.4M +$30.3M +131% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $140M $48.9M +$35.6M +270% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $104M $36.5M +$21.4M +142% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $82.8M $31.4M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $23.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $15.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.